Morgan Keegan left its Ventas VTR Outperform rating and $60 price target unchanged in a research report published today.
In the report, Morgan Keegan states, "We expect the company to report that its fourth quarter acquisition was dominated by three already-announced transactions: the pending $3.1 billion acquisition of Atria Senior Living, the $186 million acquisition of the remaining interest of 58 Sunrise facilities, and the $38 million acquisition of five medical office buildings by its Lillibridge subsidiary. In addition, we have updated our model to reflect last week's 5,563,000 share offering."
Shares of Ventas were at $53.70 in after hours trading at the time of posting, reflecting no change from Friday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in